The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Oakridge Gachibowli School Soars to New Heights with 100percent Pass Rate in CBSE Results
6th July 2024 Hyderabad, Telangana, India Oakridge International School Gachibowli is thrilled to announce the outstanding performance of its students in…
ECOVACS Launches Next-Generation DEEBOT T-Series Robotic Vacuum Cleaners to Revolutionize Smart Home Cleaning in India
MUMBAI, India, Aug. 27, 2026 /PRNewswire/ — ECOVACS, a global leader in home service robotics, today launched its new DEEBOT…
ALDO Launches New Sport Heritage Collection With ALDO Sport Club
Mumbai, India (12th September 2024) ALDO, the globally recognised footwear and accessories retailer, proudly introduces the ALDO Sport Club, a…